Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Axovia Therapeutics LTD

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT
From Axovia Therapeutics LTD
Via GlobeNewswire
Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT
From Axovia Therapeutics LTD
Via GlobeNewswire
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
From Axovia Therapeutics LTD
Via GlobeNewswire
Axovia Therapeutics Announces Presentation of Preclinical Data Supporting Lead Program AXV-101 for Treatment of Blindness Associated with BBS1 Mutations at ASGCT
From Axovia Therapeutics LTD
Via GlobeNewswire
ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies
From Axovia Therapeutics LTD
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.